Test Price
2,800 AED✅ Home Collection Available
GLUD1 Gene Hyperinsulinemic Hypoglycemia Type 6 Genetic Test in UAE | 2800 AED | DHA-Accredited
Executive Summary & Core Metrics
Executive Summary: This genetic test delivers 99.9% diagnostic sensitivity for hyperinsulinemic hypoglycemia type 6 (GLUD1-related) via ISO 9001:2015‑accredited NGS processing (Cert: INT/EGQ/2509DA/3139). Clients benefit from VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection, with results available in 3–4 weeks. Post‑test clinical guidance and direct insurance billing verification are seamlessly supported through WhatsApp at +971 54 548 8731. The entire journey is governed by Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields to guarantee your data privacy and clinical safety.
Test Overview & Methodology
The GLUD1 Gene Hyperinsulinemic Hypoglycemia Type 6 NGS Test identifies pathogenic variants in the GLUD1 gene that cause congenital hyperinsulinism‑hyperammonemia syndrome. This investigation is critical for differentiating familial forms of persistent hypoglycaemia and guiding targeted dietary or pharmacological intervention.
| Parameter | Our Test (DHA‑Accredited) | Closest Alternative |
|---|---|---|
| Precision | NGS (99.9% analytical sensitivity) | Sanger sequencing (lower throughput) |
| Methodology | Next‑Generation Sequencing (NGS) | Targeted mutation panels |
| Turnaround Time | 3 – 4 Weeks | 4 – 6 Weeks |
Physician Insight & Safety Protocols
“As a consultant in medical genetics, I emphasize that a GLUD1 variant report must always be correlated with fasting glucose, ammonia levels, and diazoxide responsiveness. No single gene result defines your child’s metabolic future – it is one piece of a deeply personal diagnostic mosaic. Please never discontinue prescribed diazoxide or octreotide without immediate consultation with your endocrinologist.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403).
Medication Advisory
⚠ Medication Warning
Genetic test results do not replace acute clinical management. Continue all prescribed therapies — including diazoxide, octreotide, or glucose infusions — until your treating physician advises otherwise.
Exclusion Criteria for Home Collection
Home phlebotomy is not available if the patient is experiencing an active hypoglycaemic crisis (blood glucose < 2.8 mmol/L), haemodynamic instability, or is aged under 1 week without a medical escort. In such cases, proceed directly to the nearest emergency department. Sample collection for this genetic test uses peripheral whole blood and is conducted via VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily from 8 AM to 11 PM).
Patient FAQ & Clinical Guidance
1. What is the GLUD1 gene test used for?
The GLUD1 gene test identifies pathogenic variants causing hyperinsulinemic hypoglycemia type 6, enabling precise diagnosis, family screening, and tailored management with diazoxide or dietary adjustments.
2. How is the sample collected for this genetic test?
A standard peripheral whole blood sample is collected via VIP Mobile Phlebotomy at your home or office. Our team follows a temperature-controlled cold-chain protocol to ensure sample integrity from collection to laboratory processing.
3. How is my genetic data protected under UAE law?
All genetic data is processed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your information is stored on encrypted servers within the UAE, and you retain full rights to data erasure.
4. When will I receive my test results?
Results are typically available within 3 to 4 weeks from sample receipt. You will be notified via WhatsApp and email, and a detailed PDF report will be shared with your referring physician.
UAE Regulatory & Data Privacy Adherence
Your privacy and safety are protected by UAE law. This test is performed under the regulatory oversight of the Dubai Health Authority (DHA Facility License No. 1143). All personal and genetic data are handled in accordance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow the standards set by Federal Decree‑Law No. 4 of 2016 on Medical Liability. Your data remains confidential and is never shared without your explicit consent.
Clinical & Logistical Metadata
| Test Name | GLUD1 Gene Hyperinsulinemic Hypoglycemia Type 6 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | E16.1 |
| LOINC Code | 82203-5 |
| DHA Facility License & Laboratory Address | License No. 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians